Document Detail

Association and prognostic impact of heart rate and micro- albuminuria in patients with type 2 diabetes and cardiovascular disease: results from the PROactive trial.
MedLine Citation:
PMID:  21088369     Owner:  NLM     Status:  MEDLINE    
AIM: Microalbuminuria (MAU) and heart rate are established predictors of an adverse cardiovascular outcome. Recently, heart rate was described as an independent predictor of MAU in hypertensive patients, raising the question of a causal link.
METHODS: In post-hoc analysis of the PROactive trial we examined the association of the baseline heart rate and MAU in diabetic patients with cardiovascular disease (n = 5,110, mean age 62 ± 8, 66% male) using logistic regression. Cox regression analysis was used to examine the independent impact of heart rate and MAU on the composite endpoint of all-cause mortality, myocardial infarction and stroke.
RESULTS: Baseline heart rate was not associated with a significantly increased risk for MAU at baseline (OR 1.01 per 10 bpm, 95% CI 0.97-1.06, p = 0.48) or MAU at the final visit (OR per 10 bpm 1.04, 95% CI 0.98-1.11, p = 0.20). Similar results were observed in subgroups of patients with hypertensive blood pressure at baseline (OR 0.98 per 10 bpm, 95% CI 0.93-1.03, p = 0.42) or patients with a history of hypertension (OR 1.02 per 10 bpm, 95% CI 0.98-1.07, p = 0.31), respectively. Stratification by use of an ACE inhibitor/AT1-receptor blocker did also not change the results. In multivariate analysis, both heart rate and MAU were significantly predictive of a cardiovascular outcome.
CONCLUSION: There was no evidence of an association between heart rate and MAU in diabetic patients with cardiovascular disease, independently of whether hypertension was present or not, but both markers were independently predictive of a cardiovascular outcome. These results do not support a causal link between heart rate and MAU.
Roman Pfister; Erland Erdmann; Christian Alfons Schneider
Related Documents :
20464269 - [evaluation of longitudinal systolic function in heart failure with normal ejection fra...
21335969 - Combination of the killip and timi classifications for early risk stratification of pat...
21509079 - Validity of cardiac markers as diagnostic and prognostic indicators of complications in...
16202889 - Intermittent cardiac troponin-i screening is an effective means of surveillance for a p...
21235679 - T-wave amplitude variability and the risk of death in chagas disease.
11557249 - Markers of myocardial damage in acute coronary syndromes--therapeutic implications.
2645479 - Angiotensin-converting enzyme inhibitors in heart failure.
10728349 - Angiogenic growth factors: potential new treatment for acute myocardial infarction?
22577429 - Chlamydia pneumoniae infection and cardiac risk factors in patients with myocardial inf...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-11-13
Journal Detail:
Title:  Journal of atherosclerosis and thrombosis     Volume:  18     ISSN:  1880-3873     ISO Abbreviation:  J. Atheroscler. Thromb.     Publication Date:  2011  
Date Detail:
Created Date:  2011-02-01     Completed Date:  2011-05-31     Revised Date:  2011-08-16    
Medline Journal Info:
Nlm Unique ID:  9506298     Medline TA:  J Atheroscler Thromb     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  65-71     Citation Subset:  IM    
Department III of Internal Medicine, Herzzentrum, University of Cologne, Cologne, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Albuminuria / complications,  physiopathology*
Cardiovascular Diseases / complications,  physiopathology*
Diabetes Mellitus, Type 2 / complications,  physiopathology*
Heart Rate*
Middle Aged

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Recent progress in antithrombotic therapy for atrial fibrillation.
Next Document:  Smoking during pregnancy increases risks of various obstetric complications: a case-cohort study of ...